Gene Kine
Latest round
- Series A
Last raised
- Oct 2018
Total raised
- Undisclosed
Investors
- 4
About Gene Kine
Established in 2012 and based in Hangzhou, China, Gene Kine operates as a biotechnology developer that mainly engaged in the research, development and production of recombinant protein glycosylation. The company mainly engaged in the research, development and production of recombinant protein glycosylation. It develops Glycoengineered Pichia Pastoris expression system, IgG full-length antibody yeast display technology platform, and Bispecific Antibodies. Display technology is used for high-throughput screening of antibodies. Recombinant protein products and technical services involve many fields such as cell biology, immunity, neuroscience, tumors, stem cells, viruses, etc. The company generates revenue by providing Glycoengineered Pichia Pastoris expression system, IgG full-length antibody yeast display technology platform, and Bispecific Antibodies.
Who invested in Gene Kine
4 investors across 2 rounds
See all investors in Gene Kine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gene Kine
Who invested in Gene Kine?
Gene Kine has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gene Kine raised?
Gene Kine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gene Kine last raise money?
Gene Kine's most recent round on record is a Series A, in Oct 2018.
What does Gene Kine do?
Established in 2012 and based in Hangzhou, China, Gene Kine operates as a biotechnology developer that mainly engaged in the research, development and production of recombinant protein glycosylation.
Where is Gene Kine headquartered?
Gene Kine is headquartered in Hangzhou, China.
Which VCs invest in companies like Gene Kine?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Gene Kine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Gene Kine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.